Dermatology Times, May 2019 (Vol. 40, No. 5)

Better awareness in disease progression and improved understanding of field cancerization has shifted the thinking in management of patients with squamous cell carcinoma.

Earlier this year, Galderma announced a new multi-disciplinary group of advisory members that compose The Women in Aesthetics Leadership Council. In this article, Dermatology Times acknowledges and congratulates the women on the advisory board who fall under the dermatology specialty.

Learn about Nano-Pulse Stimulation and how this novel technology could potentially treat both benign and malignant dermatologic lesions.

Sentinel lymph node biopsy (SLNB) has classically been performed for regional disease control and to hopefully prevent disease metastasis; however, according to this expert, there has not been any good evidence to support this practice.

Have you ever found yourself on the other side of the stethoscope? That’s what happened when Dr. Wheeland awoke one day with an asymptomatic, solitary, round, scaly patch on his ankle. Read how this experience inspired him to take a second look at how he treats patients with eczema.

Some might view the use of non-human intelligence in dermatology as a threat. But this expert believes it's up to dermatologists to transform this technology into an opportunity to ‘augment' clinical practice.

Dermatologists and their patients are among those tapping into a growing market for apps that claim to help diagnose, treat and prevent skin cancers, including melanoma.

In this month's Innovations column, Steve Xu, M.D., FAAD, begins the first part of a two-part mini-series discussing what innovators should know about intellectual property. This installment focuses on the different scenarios innovators may run into when dealing with the transfer of technological property, called technology transfer.

What is the medical value of disposable paper face masks? Is there an effective cosmetic treatment for black dot follicles? Dr. Zoe Diana Draelos answers these questions and more in this month's Cosmetic Conundrums column. 

It is common knowledge that both not-for-profit and for-profit hospitals across the U.S. have policies of charging uninsured patients more. And some physicians have done the same. But patients are starting to question these policies, landing some hospitals and physicians in hot water.

“Pretty much, I couldn’t go about my normal life,” says Benjamin Sun about a life-altering eczema flare up at age 9, which left him out of school and bedridden for weeks. Until now, children like Sun didn’t have an effective, safe option for long-term disease control. Read how dupilumab changed his quality of life, and what it can do for your pediatric patients with uncontrolled moderate to severe atopic dermatitis.

Derms don’t let other derms leave their office without SPF. Even more importantly, they shouldn’t ever let their post skin treatment patients leave without proper sun protection either.

Mothers of children with atopic dermatitis may be more likely to experience difficulty falling asleep, insufficient sleep and daytime exhaustion, according to a recent study. 

Uses for micro-focused ultrasound are expanding and researchers are finding the technology makes a measurable difference to skin physiology.

Acne mechanica usually occurs when skin is pressed against heavy clothing or bulky protective gear, but dermatologists recently discovered a case of the condition caused by friction between the inner thighs of an obese teenager.

Unlike prior generations of dermatologic drugs, Janus kinase (JAK) inhibitors show potential for treating numerous dermatologic indications. Brett King, M.D., Ph.D. explored what this class of drug has to offer in his presentation during AAD earlier this month.

Staphylococcus aureus infections are becoming more challenging to treat due to methicillin-resistant Staphylococcus aureus (MRSA). A better understanding of cutaneous immune mechanisms will identify specific immune mechanisms to target for future vaccines and immunotherapies to ultimately address this serious public health threat.

Although prescribers who provide in-office dispensing must satisfy applicable state and other requirements, a recent ruling against Allergan's attempt to shut down Prescriber's Choice appears to pave the way for expansion of these services, according to Wm. Philip Werschler, M.D.